ARWR
ARWR
NASDAQ · Biotechnology

Arrowhead Pharmaceuticals In

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$87.65
+1.82 (+2.12%)
As of Aug 8, 9:45 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -20.7% upside
Low Target $62.98
Average Target $69.50
High Target $88.85
Current Price $87.65
Current
$87.65
Target
$69.50
$62.98 $69.50 avg $88.85
Scenario Analysis
Bear Case
$62.98
-28.1%
Low target
Base Case
$69.50
-20.7%
Avg target
Bull Case
$88.85
+1.4%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$95.49
-8.2% from high
52-Week Low
$15.01
+483.9% from low
50-Day SMA
$66.84
+31.1% vs SMA
200-Day SMA
$36.65
+139.2% vs SMA
RSI (14)
36.5
Neutral
Target vs 52W High
$69.50
-27.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%